CSV and CSA FAQs: Practical Answers for Life Sciences Validation Teams
Get practical answers about CSV, CSA, risk-based testing, assurance needs, documentation, requirements, and ValGenesis support for software validation.
Welcome to the ValGenesis blog, your resource for timely insights from industry-leading experts on the trends, best practices, and new technologies impacting the life sciences.
Jan 16, 2023, 1:02:00 PM | Paperless validation technology has been available for over a decade, but the life sciences industry has been slow to adopt it. But things are changing.
Paperless validation technology has been available for over a decade, but the life sciences industry has been slow to adopt it. But things are changing.
Digitization is the process of converting text, pictures (including video), and sound into a digital form that can be processed by computer technology.
Faster innovation and time to market are top priorities for CDMOs. Being a digital-first organization gives Theragent a substantial competitive advantage.
We write about how we helped a company in accelerating the time-to-market of a drug product using a Quality by Design (QbD) framework
ROI study reveals how much time and money customers save by digitizing corporate validation processes. Watch the webinar (link in post).
When manufacturers rely on paper-based logbooks, they expose themselves to human errors, poor data integrity, and a host of compliance risks.
Technologies like blockchain, AI, ML, and AR have the potential to revolutionize validation methods and catalyze companies transitioning to Pharma 4.0.
"Digitization Of Validation For Effective Virtual Regulatory Inspections" wins IVT's Voices in Validation 2021 Podcast of the Year Award. Read transcript.
Stage 3, CPV, encompasses validation maintenance or verification that the qualified cleaning process continues to perform consistently.
Paperless validation lifecycle management systems empower regulators to conduct effective off-site regulatory reviews and inspections.
Quality Risk Management
Finding the Root Cause in mAB Production: a ValGenesis Story
Learn how we helped a customer find the root cause of a problem in monoclonal antibody (mAB) production and become stronger.
Written by
Sofia Santos
Tech Transfer & Process Scale-up
How to Accelerate Process Scale-Up With Effective Tech Transfer
There's a need to accelerate pharma product development and process scale-up. Having an effective tech transfer strategy can help you.
Written by
Sofia Santos
Cleaning Validation
Risk-Based Cleaning Validation: A Lifecycle Approach
Explore the evolution of pharmaceutical cleaning validation from compliance-focused practices to a risk-based, lifecycle-driven approach.
Written by
Kenneth Pierce
CSA flips the paradigm of traditional CSV to "right-size" validation processes. Learn more about the benefits and principles of the CSA approach, which encourages critical thinking and automation.
Get practical answers about CSV, CSA, risk-based testing, assurance needs, documentation, requirements, and ValGenesis support for software validation.
Previously
ValConnect Innovation Day Princeton: A Glimpse into the Digital Future of Life Sciences
Catalent's Journey of Continuous Improvement for CSV Excellence
Learn how digitization offers a consistent way to carry out cleaning validation lifecycle activities, ensuring your methods and procedures are risk-based and rooted in scientific evidence.
Learn how worst-case selection in cleaning validation can optimize efforts, reduce redundancy, and ensure safety in multiproduct pharma facilities.
Previously
Cleaning Validation in Pharma: FAQs on Limits, Risk, and Control
Dirty and Clean Hold Times: Setting Defensible Limits for Cleaning Validation
Waves of new technology and thinking — IoT, AR, cloud, Agile — are transforming the very foundation of validation processes. Learn how to leverage them in a Pharma 4.0 world.
Join our newsletter to receive updates on the latest news and industry-related content tailored to your preferences.